EICHOR
● Recruiting
Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
Condition: Schizophrenia and Related Disorders · Sponsor: The University of Texas Health Science Center, Houston
About this study
The purpose of this study is to provide an effective repetitive transcranial magnetic stimulation (rTMS) treatment for depressive symptoms in patients with schizophrenia. Schizophrenia patients with depressive symptoms will be exposed to rTMS to improve their symptoms.
This description comes directly from the study's public registry record.
Talk to the study team
Alina Siatka · 713-486-2740 · Alina.Siatka@uth.tmc.edu
Xiaoming Du, PhD · 443-882-9717 · Xiaoming.Du@uth.tmc.edu
Always discuss trial participation with your own doctor first.
Locations (1)
| The University of Texas Health Science Center at Houston | Houston, Texas, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07060066